Asset Details
Do you wish to reserve the book?
Repertoire of Naturally Acquired Maternal Antibodies Transferred to Infants for Protection Against Shigellosis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Repertoire of Naturally Acquired Maternal Antibodies Transferred to Infants for Protection Against Shigellosis
Do you wish to request the book?
Repertoire of Naturally Acquired Maternal Antibodies Transferred to Infants for Protection Against Shigellosis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Repertoire of Naturally Acquired Maternal Antibodies Transferred to Infants for Protection Against Shigellosis
2021
Overview
Shigella is the second leading cause of diarrheal diseases, accounting for >200,000 infections and >50,000 deaths in children under 5 years of age annually worldwide. The incidence of Shigella -induced diarrhea is relatively low during the first year of life and increases substantially, reaching its peak between 11 to 24 months of age. This epidemiological trend hints at an early protective immunity of maternal origin and an increase in disease incidence when maternally acquired immunity wanes. The magnitude, type, antigenic diversity, and antimicrobial activity of maternal antibodies transferred via placenta that can prevent shigellosis during early infancy are not known. To address this knowledge gap, Shigella- specific antibodies directed against the lipopolysaccharide (LPS) and virulence factors (IpaB, IpaC, IpaD, IpaH, and VirG), and antibody-mediated serum bactericidal (SBA) and opsonophagocytic killing antibody (OPKA) activity were measured in maternal and cord blood sera from a longitudinal cohort of mother-infant pairs living in rural Malawi. Protein-specific (very high levels) and Shigella LPS IgG were detected in maternal and cord blood sera; efficiency of placental transfer was 100% and 60%, respectively, and had preferential IgG subclass distribution (protein-specific IgG1 > LPS-specific IgG2). In contrast, SBA and OPKA activity in cord blood was substantially lower as compared to maternal serum and varied among Shigella serotypes. LPS was identified as the primary target of SBA and OPKA activity. Maternal sera had remarkably elevated Shigella flexneri 2a LPS IgM, indicative of recent exposure. Our study revealed a broad repertoire of maternally acquired antibodies in infants living in a Shigella -endemic region and highlights the abundance of protein-specific antibodies and their likely contribution to disease prevention during the first months of life. These results contribute new knowledge on maternal infant immunity and target antigens that can inform the development of vaccines or therapeutics that can extend protection after maternally transferred immunity wanes.
Publisher
Frontiers Media SA,Frontiers Media S.A
Subject
/ Adult
/ Antibodies, Bacterial - blood
/ Antigens
/ Babies
/ Diarrhea
/ Dysentery, Bacillary - immunology
/ Dysentery, Bacillary - prevention & control
/ Female
/ Humans
/ Immunity
/ Immunity, Maternally-Acquired
/ Immunoglobulin G - classification
/ Infant
/ Infants
/ Malawi
/ Male
/ Mother-offspring interactions
/ Mothers
/ Proteins
/ Ratios
/ Shigella
/ Shigella flexneri - immunology
/ Shigella Vaccines - immunology
/ transplacental antibody transfer
/ Vaccines
